Insider plans 29,700-share sale of common stock

Raju Prasad filed a notice of proposed sale of the issuer’s common stock under Rule 144.

Rhea-AI Filing Summary

Raju Prasad filed a notice of proposed sale of the issuer’s common stock under Rule 144. The planned transaction covers 29,700 common shares, to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $1,786,635.87, based on information in the filing. The shares relate to a stock option exercise on 01/06/2026, paid in cash the same day, and are expected to be sold around 01/06/2026 on the NASDAQ market, where 95,300,233 shares of this class are outstanding.

The filing also reports that over the prior three months, Prasad sold 10,000 common shares on 12/22/2025 for $559,548.00. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares are being registered for sale in this CRSP Form 144?

The notice covers a proposed sale of 29,700 shares of the issuer’s common stock, with an aggregate market value of $1,786,635.87 as indicated in the filing.

How were the 29,700 shares in the CRSP Form 144 acquired?

The 29,700 common shares were acquired on 01/06/2026 through a stock option exercise from the issuer, with the purchase price paid in cash on the same date.

Which broker and exchange are involved in this CRSP Form 144 sale?

The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are expected to be sold on the NASDAQ exchange.

How many shares of this class are currently outstanding for the issuer in the CRSP filing?

The filing states that there are 95,300,233 shares of the relevant class of common stock outstanding.

What prior share sales by Raju Prasad are disclosed in this CRSP Form 144?

Over the past three months, the filing reports that Raju Prasad sold 10,000 common shares on 12/22/2025 for $559,548.00 in gross proceeds.

What representation does the seller make in signing this CRSP Form 144?

By signing, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/06/2026 - 05:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968317
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CRISPR THERAPEUTICS AG
SEC File Number	001-37923
Address of Issuer	Baarerstrasse 14 Zug SWITZERLAND 6300
Phone	41 (0)41 561 32 77
Name of Person for Whose Account the Securities are To Be Sold	RAJU PRASAD
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	29700	1786635.87	95300233	01/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/06/2026	Stock Option Exercise	Issuer			29700	01/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RAJU PRASAD Baarerstrasse 14 Zug V8 6300	Common	12/22/2025	10000	559548.00

144: Remarks and Signature

Remarks
Date of Notice	01/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Raju Yashaswi Prasad
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)